Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German patients warm to co-payments, rate price below quality

This article was originally published in Clinica

Executive Summary

Up to two-thirds of German patients and handicapped people said that they would pay 50% or more of the cost of the standard products used in their treatment. This was one of the findings of a survey carried out by industry association Spectaris and consultancy company sa.font (Lunen), and reported by MTD-Verlag. Selection of products, functionality and level of service rendered were rated higher than price. Some two-thirds of wholesalers of these products considered that the co-payment element would rise considerably in the coming 2-5 years. In view of these findings, Spectaris saw the medtech aids quality association (QVH) playing an increasing role in overseeing the delivery of quality products in the future.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046697

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel